Track the 신일제약 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 신일제약 has recorded 54 insider filings. The latest transaction was reported on 4 June 2026 (Sale). Among the most active insiders: 홍성소. All data is free.
54
Insider Decl.
n/a
Thresholds
n/a
8 ops.
Buy Volume
n/a
5 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.